^ZURICH, June 13, 2026 (GLOBE NEWSWIRE) — As allergic diseases continue
Affecting hundreds of millions of people worldwide and health systems
increasingly burdensome, demands the European Academy of Allergy and Clinical
Immunology (EAACI) a new goal for global health: “Vision Zero” –
a future without the burden of allergies and asthma.
This vision will be the central theme of the 2026 EAACI Annual Congress
will take place from June 12th to 15th, 2026 in Istanbul (Türkiye). There will be
Thousands of clinicians, researchers and healthcare professionals
gather to discuss the latest scientific advances and the future of the
Discuss allergy and asthma treatment.
Instead of seeing allergic and respiratory diseases as unavoidable and increasing
EAACI is the public health challenge
View that scientific innovations, prevention strategies and
coordinated policy measures their impact on individuals,
families and societies can significantly reduce.
“Vision Zero reflects our determination to move beyond the treatment of
diseases and focus on preventing and reducing them
to address the burden of disease,” said María Torres, President of EAACI.?The
The scientific progress we are experiencing today gives us reason to be ambitious
to be. Through collaboration between research, clinical practice and the
In public health, we can work towards a future in which
Allergies and asthma will no longer limit the lives of millions of people.”
The congress will present current research results and clinical developments
the areas of immunotherapy, environmental and genetic factors, digital
Introduce health technologies, precision medicine and preventative approaches. In the
The discussions also focus on equal health opportunities
and the need to ensure that advances in allergy and
Asthma treatment is available to patients worldwide.
Allergic diseases are among the most common chronic diseases worldwide
diseases, with their prevalence continuing to increase in many regions. The
Burden extends beyond healthcare and impacts education,
Productivity, quality of life and psychological well-being. Before this one
Background, the EAACI’s “Vision Zero” initiative aims to:
to stimulate long-term thinking about what is possible when scientific
Insights with effective implementation and policy support
accompany.
“The concept of Vision Zero challenges us to think differently,” says André
Moreira, Vice President of Congresses of the EAACI.?It excites the allergy community
to focus not only on treating diseases,
but also on their prevention, the reduction of their effects and the
Creating healthier living environments for future generations.”
Istanbul, which lies at the interface between Europe and Asia, offers the
perfect framework for international cooperation and knowledge exchange. The
Congress is intended to bring together experts from all over the world to discuss progress
to accelerate the path to a future in which the burden of allergies
and asthma is significantly reduced.
About the EAACI
The European Academy of Allergy and Clinical Immunology (EAACI) is the leading one
Specialist organization committed to excellence in allergy and immunology.
The EAACI advocates through research, education, advocacy and the
Promoting quality patient care to improve the
health of people affected by allergic diseases.
Media contact: [email protected] (mailto:[email protected])
°